Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute and chronic rejection.

A Tejani1, L Emmett

  • 1Department of Pediatrics and Surgery, New York Medical College, Valhalla, NY, USA. Atejani@aol.com

Seminars in Nephrology
|September 18, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Local and locoregional prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Five-year analysis of neoadjuvant dabrafenib and trametinib for stage III melanoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Long-term outcomes of SBRT for PSMA PET detected oligometastatic prostate cancer.

Radiation oncology (London, England)·2023
Same author

Resistance to local anaesthetics administered via epidural, intrathecal and pudendal injections.

Anaesthesia reports·2022
Same author

The challenges and opportunities for implementing group antenatal care ('Pregnancy Circles') as part of standard NHS maternity care: A co-designed qualitative study.

Midwifery·2022
Same journal

Current Options for Kidney Protection: Are Renin-Angiotensin System Inhibitors Still Relevant?

Seminars in nephrology·2026
Same journal

Proposed Role for Quantitative Podocyturia as a Clinical Marker of Systemic Endothelial Injury: Implications for Cardiovascular Disease and Longevity.

Seminars in nephrology·2026
Same journal

Kidney Protection Options in 2025: Are Renin-Angiotensin System Inhibitors Still Needed?

Seminars in nephrology·2026
Same journal

From Nephron Number to Global Health.

Seminars in nephrology·2026
Same journal

Chronic Kidney Disease Progression Mechanisms: Why They Matter in an Era of Novel Kidney Protective Therapies.

Seminars in nephrology·2026
Same journal

Of Diuretics, Transporters, and Mechanisms of Hypertension.

Seminars in nephrology·2026
See all related articles

Graft rejection is driven by T-cell recognition of major histocompatibility complex molecules. While acute rejection decreases with therapy, chronic rejection is rising, impacting long-term renal transplant success, especially in children.

Area of Science:

  • Immunology
  • Transplantation Biology
  • Nephrology

Background:

  • Major histocompatibility complex (MHC) molecules are key antigens in graft rejection.
  • T-cell recognition of alloantigens initiates cellular rejection, with direct and indirect pathways implicated in acute and chronic rejection, respectively.
  • Cytotoxic T-lymphocyte molecules are upregulated in rejecting human renal allografts.

Purpose of the Study:

  • To elucidate the mechanisms of acute and chronic graft rejection.
  • To highlight the differential incidence and trends of acute versus chronic rejection.
  • To emphasize the need for improved strategies for long-term renal transplant outcomes in children.

Main Methods:

  • Analysis of rejecting human renal allograft biopsy tissues.

Related Experiment Videos

  • Review of current concepts in T-cell mediated allorecognition.
  • Examination of epidemiological data on graft rejection rates and trends.

    • Main Results:

    • Direct allorecognition is linked to acute rejection, while indirect allorecognition is associated with chronic rejection.
    • Upregulation of cytotoxic T-lymphocyte molecules observed in rejecting renal allografts.
    • Acute rejection incidence is decreasing due to improved immunosuppression, but chronic rejection-related graft loss is increasing.
    • Acute rejection is more prevalent in pediatric recipients.

    Conclusions:

    • Understanding T-cell mediated allorecognition is crucial for managing graft rejection.
    • The shift towards increased chronic rejection necessitates novel therapeutic approaches.
    • Improving graft half-life in pediatric renal transplantation requires addressing chronic rejection mechanisms.